Molecular Health is an international biotech company headquartered in Germany that has been developing innovative software in the field of in-silico and precision medicine since 2004. Our solutions enable the conversion of large volumes of data into evidence-based, medically relevant results for healthcare professionals. We provide molecular pathologists, physicians, and patients with comprehensive information about diagnoses and treatment options. We support pharmaceutical and health organizations in optimizing clinical studies and developing disease models. At Molecular Health, specialists from the fields of medicine, data science, biology, and bioinformatics, as well as software development, strive to make Big Data work for healthcare. The result is a range of intuitive high-performance applications tailored to a broad spectrum of requirements in healthcare. Our AI Pharma Solutions help researchers, drug manufacturers, and biotech companies to enhance their capabilities to select and evaluate better targets, to reduce attrition, and to optimize clinical development. Using artificial intelligence (AI), our data-driven, unbiased approach is complementary to the traditional R&D approach and leads to better results for drug discovery, development, and hypothesis generation. Our in-silico technologies enhance and facilitate unbiased exploratory R&D and allow pharmaceutical companies to optimize their program and portfolios, and to identify promising drug candidates early on.